Recruiting

Developing a Booster Session for Problem Management Plus in the Bahamas: A Pilot Randomized Controlled Trial

Therapists at the Grand Bahama Resilience Center (GBRC) will be trained to deliver Problem Management Plus (PM+), a WHO intervention. Then, those therapists will deliver PM+ (5 one-on-one skills-based sessions) to a total of 50 adult clients experiencing mild to moderate mental health difficulties (excluding anyone with cognitive difficulties or psychosis). Participants will complete (de-identified) self-report survey assessments before PM+, after PM+, 3 months later, and 6 months later. After receiving 5 sessions…

ClinicalTrials.gov IDNCT07208851
PhaseNA
Enrollment50
SponsorThe New School
Age18 Years
SexALL
I'm interested View official listing

Conditions studied

Depression Symptoms, Anxiety Symptoms

About this study

Therapists at the Grand Bahama Resilience Center (GBRC) will be trained to deliver Problem Management Plus (PM+), a WHO intervention. Then, those therapists will deliver PM+ (5 one-on-one skills-based sessions) to a total of 50 adult clients experiencing mild to moderate mental health difficulties (excluding anyone with cognitive difficulties or psychosis). Participants will complete (de-identified) self-report survey assessments before PM+, after PM+, 3 months later, and 6 months later. After receiving 5 sessions of PM+, participants will be randomized to either receive a one-time booster session of PM+ (to be co-created by the PI and the GBRC providers) three months later or to a control group which will receive a phone call reminding them that they will receive their third assessment soon.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Adults of 18 years or above * English-speaking * A score of \<91 on Global Assessment of Functioning * Located in the Bahamas Exclusion Criteria: * ● Imminent suicide risk (assessed at screening using Columbia Suicide-Severity Rating Scale, see document titled " Screener updated 10-30- 24") * Severe mental disorder (e.g. psychotic disorders) * Severe cognitive impairment (e.g. severe intellectual disability or dementia)

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.